| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10999313 | Veterinary Anaesthesia and Analgesia | 2007 | 8 Pages |
Abstract
Etomidate in the commercial drug product is solubilized with propylene glycol, a cosolvent associated with adverse side effects on injection. An aqueous formulation of etomidate has been developed, which utilizes SBE-CD as a solubilizing agent. The data suggest that the SBE-CD etomidate formulation may be a safer IV induction formulation than the commercial etomidate drug product.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Animal Science and Zoology
Authors
Michelle P PhD, Hideyuki MD, Yoshiyuki MD, Roger A PhD, Hiroshi MD,